| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |